Product NDC: | 65224-560 |
Proprietary Name: | Aldex |
Non Proprietary Name: | PSEUDOEPHEDRINE HYDROCHLORIDE, GUAIFENESIN, and DEXTROMETHORPHAN HYDROBROMIDE |
Active Ingredient(s): | 15; 190; 30 mg/1; mg/1; mg/1 & nbsp; PSEUDOEPHEDRINE HYDROCHLORIDE, GUAIFENESIN, and DEXTROMETHORPHAN HYDROBROMIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65224-560 |
Labeler Name: | Pernix Therapeutics, LLC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20110321 |
Package NDC: | 65224-560-01 |
Package Description: | 100 TABLET in 1 BOTTLE (65224-560-01) |
NDC Code | 65224-560-01 |
Proprietary Name | Aldex |
Package Description | 100 TABLET in 1 BOTTLE (65224-560-01) |
Product NDC | 65224-560 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | PSEUDOEPHEDRINE HYDROCHLORIDE, GUAIFENESIN, and DEXTROMETHORPHAN HYDROBROMIDE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110321 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Pernix Therapeutics, LLC |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE |
Strength Number | 15; 190; 30 |
Strength Unit | mg/1; mg/1; mg/1 |
Pharmaceutical Classes |